FibroGen, Inc.
FGEN
$10.48
$0.131.26%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.35M | 2.74M | 3.14M | 46.33M | 998.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.35M | 2.74M | 3.14M | 46.33M | 998.00K |
| Cost of Revenue | 5.95M | 9.43M | 1.03M | 27.00M | 32.50M |
| Gross Profit | -4.60M | -6.69M | 2.11M | 19.33M | -31.50M |
| SG&A Expenses | 7.06M | 8.11M | 8.35M | 17.55M | 14.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.01M | 17.53M | 9.37M | 44.56M | 47.41M |
| Operating Income | -11.66M | -14.79M | -6.23M | 1.78M | -46.41M |
| Income Before Tax | -13.78M | -16.76M | -8.66M | -17.07M | -47.38M |
| Income Tax Expenses | -92.00K | 2.00K | 2.00K | 12.00K | -281.00K |
| Earnings from Continuing Operations | -13.68M | -16.77M | -8.67M | -17.08M | -47.10M |
| Earnings from Discontinued Operations | 6.08M | 21.41M | 26.65M | -- | 31.55M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.60M | 4.64M | 17.98M | -17.08M | -15.54M |
| EBIT | -11.66M | -14.79M | -6.23M | 1.78M | -46.41M |
| EBITDA | -11.44M | -14.47M | -5.88M | 2.52M | -45.63M |
| EPS Basic | -1.88 | 1.15 | 4.46 | -4.25 | -3.89 |
| Normalized Basic EPS | -2.07 | -2.58 | -1.20 | 0.23 | -7.42 |
| EPS Diluted | -1.88 | 1.15 | 4.46 | -4.25 | -3.89 |
| Normalized Diluted EPS | -2.07 | -2.58 | -1.20 | 0.23 | -7.42 |
| Average Basic Shares Outstanding | 4.04M | 4.04M | 4.03M | 4.02M | 3.99M |
| Average Diluted Shares Outstanding | 4.04M | 4.04M | 4.03M | 4.02M | 3.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |